Optimizing Application And Support Of Immunization Information Systems (OASIS)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Stanley J Schaffer, MD, University of Rochester
ClinicalTrials.gov Identifier:
NCT02010372
First received: December 9, 2013
Last updated: July 16, 2014
Last verified: July 2014
  Purpose

The overall purpose of this study is to evaluate the use of features of the New York State Immunization Information System (NYSIIS) by various types of primary care practices and determine how best to promote the use of IIS features and functionality. The primary goal is to promote the use of NYSIIS for immunization quality improvement (QI) in the practice setting. Customized training sessions will be conducted by study staff to educate practices on NYSIIS' enhanced features.


Condition Intervention
Increase in Use of Immunization Registry
Increase in HPV Vaccination Rate
Other: Reminder Recall Report
Other: Audit-Feedback/Immunization Forecasting Reports

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Optimizing the Practical Application of Immunization Information System Use in Primary Care Practices

Further study details as provided by University of Rochester:

Primary Outcome Measures:
  • NYSIIS report usage [ Time Frame: One Year ] [ Designated as safety issue: No ]
    Practice NYSIIS administrators will monitor the number of reports their practice generates throughout the 12 month post-training period. These measures for control and intervention practices will be compared in bivariate and multivariate analysis.


Secondary Outcome Measures:
  • HPV Vaccination Rate [ Time Frame: One Year ] [ Designated as safety issue: No ]
    HPV Vaccination rates will be measured to determine the change in the practice's immunization levels (for the pre-determined immunization QI goal) over the 12-month period following their initial training. Statistical comparisons of control and intervention practice will be performed using bivariate analyses, while multivariate analyses will be used to account for the effects of practice characteristics.


Enrollment: 31
Study Start Date: December 2013
Estimated Study Completion Date: August 2015
Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Reminder Recall Reports
Training in how to use reminder-recall reports in the Immunization registry will be given to administrators who will then be asked to regularly run these reports for a period of one year.
Other: Reminder Recall Report
Practices (administrators) that are randomized to this intervention will receive training in how to run reminder recall reports for patients due to receive any dose of HPV vaccine. After the training has been completed, administrators will be asked to continue running regularly scheduled reports over the course of one year. A tracking log will be sent regularly to the research team.
Experimental: Audit-Feedback/Immunization Forecasting Reports
Training in how to use audit-feedback/immunization forecasting reports in the Immunization registry will be given to administrators who will then be asked to regularly run these reports for a period of one year.
Other: Audit-Feedback/Immunization Forecasting Reports
Practices (administrators) that are randomized to this intervention will receive training in how to run audit-feedback/immunization forecasting reports for patients due to receive any dose of HPV vaccine and to determine the % of patients in their practice who have received at least one dose of HPV vaccine within the study period. After the training has been completed, administrators will be asked to continue running regularly scheduled reports over the course of one year. A tracking log will be sent regularly to the research team.
No Intervention: Control
No intervention will be administered to this group.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • NYSIIS administrator at a participating practice

Exclusion Criteria:

  • Practices already utilizing/running reports used in the intervention
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02010372

Locations
United States, New York
University of Rochester
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
Investigators
Principal Investigator: Stanley J Schaffer, MD, MPH University of Rochester
  More Information

No publications provided

Responsible Party: Stanley J Schaffer, MD, Principal Investigator, University of Rochester
ClinicalTrials.gov Identifier: NCT02010372     History of Changes
Other Study ID Numbers: 5U01IP000502
Study First Received: December 9, 2013
Last Updated: July 16, 2014
Health Authority: United States: Federal Government

Keywords provided by University of Rochester:
Immunization Registry
Human Papillomavirus

ClinicalTrials.gov processed this record on August 21, 2014